RAD1901
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RAD1901, covering 2012-03-26 to 2019-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 2]